全文获取类型
收费全文 | 5537篇 |
免费 | 630篇 |
国内免费 | 168篇 |
专业分类
耳鼻咽喉 | 55篇 |
儿科学 | 220篇 |
妇产科学 | 140篇 |
基础医学 | 120篇 |
口腔科学 | 78篇 |
临床医学 | 1243篇 |
内科学 | 1278篇 |
皮肤病学 | 120篇 |
神经病学 | 308篇 |
特种医学 | 183篇 |
外科学 | 1591篇 |
综合类 | 15篇 |
预防医学 | 356篇 |
眼科学 | 326篇 |
药学 | 43篇 |
肿瘤学 | 259篇 |
出版年
2023年 | 106篇 |
2021年 | 66篇 |
2020年 | 97篇 |
2019年 | 43篇 |
2018年 | 125篇 |
2017年 | 171篇 |
2016年 | 183篇 |
2015年 | 139篇 |
2014年 | 226篇 |
2013年 | 302篇 |
2012年 | 96篇 |
2011年 | 116篇 |
2010年 | 228篇 |
2009年 | 338篇 |
2008年 | 129篇 |
2007年 | 64篇 |
2006年 | 106篇 |
2005年 | 78篇 |
2004年 | 38篇 |
2003年 | 57篇 |
2002年 | 42篇 |
2001年 | 112篇 |
2000年 | 70篇 |
1999年 | 135篇 |
1998年 | 176篇 |
1997年 | 200篇 |
1996年 | 305篇 |
1995年 | 255篇 |
1994年 | 200篇 |
1993年 | 117篇 |
1992年 | 124篇 |
1991年 | 138篇 |
1990年 | 67篇 |
1989年 | 138篇 |
1988年 | 105篇 |
1987年 | 82篇 |
1986年 | 104篇 |
1985年 | 85篇 |
1984年 | 92篇 |
1983年 | 76篇 |
1982年 | 71篇 |
1981年 | 65篇 |
1980年 | 85篇 |
1979年 | 43篇 |
1978年 | 62篇 |
1977年 | 45篇 |
1976年 | 43篇 |
1975年 | 46篇 |
1964年 | 49篇 |
1963年 | 48篇 |
排序方式: 共有6335条查询结果,搜索用时 46 毫秒
81.
Increased placental apoptosis in intrauterine growth restriction 总被引:2,自引:0,他引:2
Stephen C. Smith MB ChB Philip N. Baker DM E.Malcolm Symonds MD 《American journal of obstetrics and gynecology》1997,177(6):1395-1401
OBJECTIVES: Our purpose was to investigate a possible role for apoptosis in the pathophysiologic mechanisms of intrauterine growth restriction. STUDY DESIGN: Placental samples were obtained from 43 uncomplicated third-trimester pregnancies and from 26 pregnancies complicated by intrauterine growth restriction. The definition used to identify cases of intrauterine growth restriction depended on three criteria: clinical evidence of suboptimal growth, ultrasonographic evidence of deviation from an appropriate growth percentile, and individualized birth weight ratios <10th percentile. Light microscopy was used to quantify the incidence of apoptosis. Electron microscopy and TUNEL (terminal deoxynucleotidyl transferase–mediated deoxyuridine triphosphate nick end labeling) staining were used to confirm the occurrence of apoptosis. RESULTS: Quantification of apoptosis (medians and interquartile ranges) resulted in the following values: normal third trimester (n = 43) 0.14% of cells (0.08% to 0.20%) and intrauterine growth restriction third trimester (n = 26) 0.24% of cells (0.16% to 0.29%). The incidence of apoptosis was significantly higher in placentas from pregnancies with intrauterine growth restriction compared with normal third-trimester placentas (p < 0.01, Mann Whitney U test). CONCLUSIONS: These results suggest that apoptosis may play a role in the pathophysiologic mechanisms of intrauterine growth restriction.(Am J Obstet Gynecol 1997;177:401) 相似文献
82.
MB Popli N Mehta VS Nijhavan V Popli 《Journal of Medical Imaging and Radiation Oncology》1998,42(3):256-257
Congenital tuberculosis is a rare disease. The non-specific nature of presenting signs and symptoms (because of the lack of host response) and the fatal outcome in the absence of early therapy all underscore the importance of early diagnosis and treatment in infants. Recognition requires awareness that tuberculosis at this age has manifestations not found in older children. Here a case of congenital tuberculosis is presented, where changes were confined only to the thorax. Tuberculosis in the mother could be diagnosed only retrospectively. 相似文献
83.
84.
Graham G Dark A Hilary Calvert Robert Grimshaw Christopher Poole Ken Swenerton Stan Kaye Robert Coleman Gordon Jayson Tien Le Susan Ellard Marc Trudeau Paul Vasey Marta Hamilton Terri Cameron Emma Barrett Wendy Walsh Lynn McIntosh Elizabeth A Eisenhauer 《Journal of clinical oncology》2005,23(9):1859-1866
PURPOSE: Liposomal lurtotecan (OSI-211) is a liposomal formulation of the water-soluble topoisomerase I inhibitor lurtotecan (GI147211), which demonstrated superior levels of activity compared with topotecan in preclinical models. We studied two schedules of OSI-211 in a randomized design in relapsed ovarian cancer to identify the more promising of the two schedules for further study. PATIENTS AND METHODS: Eligible patients had measurable epithelial ovarian, fallopian, or primary peritoneal cancer that was recurrent after one or two prior regimens of chemotherapy. Patients were randomly assigned to receive either arm A (OSI-211 1.8 mg/m(2)/d administered by 30-minute intravenous infusion on days 1, 2, and 3 every 3 weeks) or arm B (OSI-211 2.4 mg/m(2)/d administered by 30-minute intravenous infusion on days 1 and 8 every 3 weeks). The primary outcome measure was objective response, which was confirmed by independent radiologic review, and a pick the winner statistical design was used to identify the schedule most likely to be superior. RESULTS: Eighty-one patients were randomized between October 2000 and September 2001. The hematologic toxic effects were greater on arm A than on arm B (grade 4 neutropenia, 51% v 22%, respectively), as was febrile neutropenia (26% v 2.4%, respectively). Of the 80 eligible patients, eight patients (10%) had objective responses; six responders (15.4%; 95% CI, 6% to 30%) were in arm A and two responders (4.9%; 95% CI, 1% to 17%) were in arm B. CONCLUSION: The OSI-211 daily for 3 days intravenous schedule met the statistical criteria to be declared the winner in terms of objective response. This schedule was also associated with more myelosuppression than the schedule of OSI-211 administered in arm B. 相似文献
85.
86.
Until recently, axillary node clearance had long been the standard of care in patients with axillary node-positive disease. One stop nucleic acid sampling (OSNA) has been used to guide intraoperative decision-making regarding suitability for axillary node clearance (ANC). The aim of this study is to evaluate the use of OSNA following neoadjuvant chemotherapy (NACT) and whether it can predict lymph node burden in ANC. A single center, prospective cohort study was performed on 297 patients having OSNA between 2016 and 2019. Patients were sub-classified according to node positivity at diagnosis and those treated with NACT and outcomes included copy number and lymph node harvest. Axillary complete pathological response was observed in 24/36 patients (67%) following NACT. 14/16 patients (87%) having axillary node clearance had axillary node disease limited to 4 nodes. OSNA copy numbers were significantly higher in patients showing disease progression following NACT. Overall, 73% of patients with lymph node positivity at diagnosis could be successfully treated with a combination of NACT and lymph node excision of four nodes. De-escalating axillary surgical treatment to resection of four nodes following NACT may be effective in balancing oncological resection and limiting treatment morbidity. ONSA can correctly identify patients experiencing disease progression who would benefit from traditional three-level ANC. 相似文献
87.
88.
89.
90.
The perspectives of stakeholders of intellectual disability liaison nurses: a model of compassionate,person‐centred care
下载免费PDF全文
![点击此处可从《Journal of clinical nursing》网站下载免费的PDF全文](/ch/ext_images/free.gif)